Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 27, 2021
Nexelis has signed an asset purchase agreement with GSK to acquire its GCLP-certified clinical bioanalytical laboratory located in Marburg, Germany.
read more
Servier CDMO announced the company has invested $7.5 million in intensified technology including continuous chromatography with SMB and SFC with solvent recycling of up to 90% to lower environmental impact.
read more
Forge Biologics, a gene therapy-focused contract development and manufacturing organization (CDMO), announced the appointment of John Maslowski to the newly created role of Chief Commercial Officer. Mr. Maslowski brings significant gene therapy ...
read more
Biosynth has acquired Cambridge Research Biochemicals (“CRB”), a producer of custom-made peptide and antibody tools, based in the UK and supplying researchers in the pharmaceutical, life science and academic sectors.
read more
Cambrex Corporation has announced the completion and validation of a $50 million state-of-the-art production and warehousing expansion at its cGMP Charles City, Iowa site. The investment in capacity and capabilities was made in reflection of strong ...
read more
Paragon Bioservices has appointed Gerard Fleury as Chief Financial Officer.
read more
Quotient Sciences, a drug development and manufacturing accelerator, completed major investments and expansions at its Nottingham, UK and Reading, UK, facilities to support the delivery of fully integrated drug development programs through the ...
read more
Thursday, December 11, 2025
ProPharma, a provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, announced the official inauguration of its new office in Hyderabad, India.
read more
Friday, September 04, 2020
JanOne has confirmed stability of its developmental batch run of JAN101.
read more
Tuesday, November 24, 2020
Isohelix announced its GeneFiX Saliva RNA Collection Device is the technology of choice for COVID-19 testing by Precision Genetics.
read more
Pergamum AB announced today that several end-points were met in a randomized Phase II trial of PXL-01 for prevention of post-surgical adhesions. Karolinska Development AB is the majority owner of Pergamum.
read more
Tuesday, January 05, 2021
Slayback Pharma has received final approval for its ANDA for Merzee 1 mg/20 mcg from the FDA with a Competitive Generic Therapy Designation.
read more
Catalent announced that its Board of Directors has appointed Alessandro Maselli, currently President and Chief Operating Officer, as the company’s next President and Chief Executive Officer, effective July 1, 2022.
read more
Tuesday, November 08, 2016
INC Research Holdings, a global Phase I to IV contract research organization, has announced its involvement in The Leukemia & Lymphoma Society’s (LLS) recently-launched precision medicine Master Trial to treat acute myeloid leukemia (AML).
read more
ERT announced the acquisition of ImageIQ, originally established as Cleveland Clinic’s Biomedical Imaging and Analysis Center.
read more